UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5701
Columbia Financial
CLBK
$1.13B
| $598K | ﹤0.01% |
37,825
+13,437
| +55% | +$232K |
|
5702
Atomera
ATOM
$214M
| $596K | ﹤0.01% |
51,420
+43,202
| +526% | +$249K |
|
5703
ProShares UltraShort S&P500
SDS
$369M
| $595K | ﹤0.01% |
6,048
+5,482
| +969% | +$542K |
|
5704
PUT
Immunovant
IMVT
$8.25B
| $594K | ﹤0.01% |
24,000
| – | – |
|
|
LAC
5705
CALL
Lithium Americas
LAC
$1.17B
| $594K | ﹤0.01% |
+200,000
| New | +$693K |
|
5706
Phunware
PHUN
$43.6M
| $593K | ﹤0.01% |
114,073
+101,202
| +786% | +$559K |
|
|
SBI
5707
Western Asset Intermediate Muni Fund
SBI
$108M
| $592K | ﹤0.01% |
76,527
-18,984
| -20% | -$153K |
|
|
WIA
5708
Western Asset Inflation-Linked Income Fund
WIA
$186M
| $591K | ﹤0.01% |
73,891
-1,068
| -1% | -$8.82K |
|
5709
Electromed
ELMD
$349M
| $590K | ﹤0.01% |
19,952
+17,663
| +772% | +$461K |
|
5710
CALL
Ribbon Communications
RBBN
$383M
| $588K | ﹤0.01% |
141,400
| – | – |
|
|
SLRN
5711
DELISTED
ACELYRIN
SLRN
| $587K | ﹤0.01% |
187,005
+148,199
| +382% | +$718K |
|
5712
State Street SPDR S&P Kensho Clean Power ETF
CNRG
$208M
| $586K | ﹤0.01% |
9,676
+2,837
| +41% | +$177K |
|
|
SCWX
5713
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $585K | ﹤0.01% |
69,179
+58,742
| +563% | +$490K |
|
5714
PUT
Compass
COMP
$9.66B
| $585K | ﹤0.01% |
100,000
-5,000
| -5% | -$31.7K |
|
5715
Defiance Quantum ETF
QTUM
$5.65B
| $584K | ﹤0.01% |
7,200
+6,768
| +1,567% | +$467K |
|
5716
Tonix Pharmaceuticals
TNXP
$192M
| $584K | ﹤0.01% |
17,701
+15,298
| +637% | +$318K |
|
5717
Capital City Bank Group
CCBG
$890M
| $584K | ﹤0.01% |
15,928
-30,184
| -65% | -$1.11M |
|
5718
ALPS Clean Energy ETF
ACES
$124M
| $584K | ﹤0.01% |
22,414
-7,722
| -26% | -$214K |
|
5719
Financial Institutions
FISI
$821M
| $582K | ﹤0.01% |
21,340
+8,925
| +72% | +$235K |
|
5720
CALL
Sigma Lithium
SGML
$1.28B
| $582K | ﹤0.01% |
+51,900
| New | +$679K |
|
|
SDHY
5721
PGIM Short Duration High Yield Opportunities Fund
SDHY
$401M
| $582K | ﹤0.01% |
36,096
-3,612
| -9% | -$59.7K |
|
5722
Rekor Systems
REKR
$91.7M
| $581K | ﹤0.01% |
372,644
+320,275
| +612% | +$332K |
|
5723
JPMorgan High Yield Municipal ETF
JMHI
$293M
| $581K | ﹤0.01% |
11,567
+1,518
| +15% | +$76.8K |
|
5724
Sono-Tek
SOTK
$82.8M
| $580K | ﹤0.01% |
144,734
-4,674
| -3% | -$20.7K |
|
5725
Palmer Square Capital BDC
PSBD
$320M
| $580K | ﹤0.01% |
38,148
+16,398
| +75% | +$261K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.